1Lamm DL.Prophylaxis for recurrent transitional cell carcinoma[J].Urology,1991,37(5):21-23.
2Amling CL.Diagnosis and management of superficial bladder cancer[J].Curr Probl Cancer,2001,25(4):219-278.
3Kaasinen E,Rintala E,Anna-Kaisa P,et al.Weekly mitomycin C followed by monthly bacillus calmette-guerin for prophylaxis of recurrent papillary superficial bladder carcinoma[J].J Urology,2000,164(7):47-52.
4Takahashi T,Kushiro A,Nomoto K,et al.Antitumor effects of the intravesical instillation of heat killed cells of the lactobacillus casei strain shirota on the murine orthotopic bladder tumor MBT-2[J].J Urology,2001,166(12):2506-2511.
5Kawamura S,Fujioka T,Kubo T,et al.A course of pirarubicin vesical irrigation at 30mg effectively prevent spost-TUR recurrence of superficial bladder cancer[J].Jpn J Cancer Chemother,1996,23(4):465-470.
6Okamura K,Ono Y,Kinukawa T,et al.Randomized study of single early instillation of (2″R)-4′-O-tetrahydropyranly-doxombidn for a single superficial bladder carcinoma[J].Cancer,2002,94(1):2363-2368.
5Nio Y,Nagami H,Tamura K,et al.Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion[J].British Journal of Cancer,1999,80(5/6):775-785.
6Nariaki N,Tanaka A,OharaT,et al.Intratamoral injection of a streptococcal prepation,ok-432[J].Befiore Surgery for Gaseric Cancer,1994,1574(12):1 097-1 103.
